A not for profit organisation

Request an appointment

Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1-3 tyrosine kinase inhibitor anticancer therapy

Home Research Research Publication Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1-3 tyrosine kinase inhibitor anticancer therapy

Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1-3 tyrosine kinase inhibitor anticancer therapy.

Charng J, Attia MS, Arunachalam S, Lam WS, Creaney J, Muruganadan S, Read C, Millward M, Spiro J, Chakera A, Lee YCG, Nowak AK, Chen FK.

Clin Exp Ophthalmol. 2021 May 2. doi: 10.1111/ceo.13940. Online ahead of print.

PMID: 33934469

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Phone
(08) 9381 0777
Email
carecentre@lei.org.au

Request an appointment